Novartis Annual Results

Annual Results 2018 - Jan 30, 2019

Media release

English (PDF 0.1 MB)

Deutsch (PDF 0.1 MB)

Français (PDF 0.2 MB)

Condensed financial report (PDF 0.6 MB)

Webcast and presentations

Media

Watch the webcast

Download the presentation (PDF 3.2 MB)

Investors

Watch the webcast

Read the presentation transcript

Download the podcast (MP3 51 MB)

Download the presentation (PDF 3.4 MB)

---

2018 Annual Reporting Suite

The Annual Review, our new corporate report, explains who we are and what we do, and highlights our progress against the company’s five strategic priorities in 2018.

To request a hard copy of the Annual Report, fill out the order form.

Download the Annual Report 2018 (PDF 3.8 MB)

Visit the 2018 Annual Reporting Suite section

 

---

Form 20-F

Form 20-F documents Novartis results in line with requirements of the US Securities and Exchange Commission (SEC).

English (PDF 3.7 MB)

---

XBRL package

Documents Novartis results in XML format in line with requirements of the US Securities and Exchange Commission (SEC).

XBRL Package (ZIP 0.7 MB)

Annual Results 2017 - Jan 24, 2018

 

Key figures1	FY 2017 (USD m)	FY 2016 (USD m)	% change (USD/cc)
Net sales	49,109	48,518	1 (cc: 2)
Operating income	8,629	8,268	4 (cc: 7)
Net income	7,703	6,698	15 (cc: 12)
EPS (USD)	3.28	2.82	16 (cc: 14)
Free cash flow	10,428	9,455	10
Core
Operating income	12,850	12,987	-1 (cc: 0)
Net income	11,391	11,314	1 (cc: 2)
EPS (USD)	4.86	4.75	2 (cc: 3)

 

1. Constant currencies (cc), core results and free cash flow are non-IFRS measures. An explanation of non-IFRS measures can be found on page 42 of the Condensed Financial Report. Unless otherwise noted, all growth rates in this Release refer to same period in prior year.

 

Media release

English (PDF 0.4 MB)

Deutsch (PDF 0.3 MB)

Français (PDF 0.5 MB)

 

Condensed financial report (PDF 0.5 MB)

---

Download the presentation (PDF 2.8 MB)

Download the podcast (MP3 40 MB)

Annual Results 2015 - Jan 27, 2016

 

Continuing operations2
Key figures1	FY 2015 (USD m)	FY 2014 (USD m)	% change (USD/cc)
Net sales	49,414	52,180	-5 (cc: 5)
Operating income	8,977	11,089	-19 (cc: -2)
Net income	7,028	10,727	-34 (cc: -18)
EPS (USD)	2.92	4.39	-33 (cc: -17)
Free cash flow	9,259	10,934	-15
Core
Operating income	13,790	14,473	-5 (cc: 10)
Net income	12,041	12,653	-5 (cc: 9)
EPS (USD)	5.01	5.19	-3 (cc: 10)

 

1. Constant currencies (cc), core results and free cash flow are non-IFRS measures. An explanation of non-IFRS measures can be found on page 53 of the Condensed Financial Report. Unless otherwise noted, all growth rates in this Release refer to same period in prior year.

2. Refers to continuing operations, defined on page 43 of the Condensed Financial Report.

 

Media release

English (PDF 0.5 MB)

Deutsch (PDF 0.5 MB)

Français (PDF 0.8 MB)

 

Condensed financial report (PDF 0.6 MB)